SS&C Technologies Holdings Inc has successfully completed a significant $1.2 billion private offering of convertible senior notes. This strategic financial move is designed to bolster the company's financial resources and support its growth initiatives.
On November 6, 2026, the company finalized the upsized offering of 2.75% Convertible Senior Notes due 2031. This includes $150 million from the exercise of an option by initial purchasers to buy additional notes. The notes will mature on December 1, 2031, unless converted, redeemed, or repurchased before that date.
The offering is a clear indication of SS&C's strategy to enhance its capital structure, allowing it to invest in growth opportunities while managing its debt levels effectively. The notes are senior unsecured obligations, guaranteed by SS&C Technologies, Inc., a wholly owned subsidiary, and other domestic subsidiaries.
Background
SS&C Technologies Holdings Inc, a leading provider in the prepackaged software industry (SIC 7372), is known for its innovative solutions that support financial services and healthcare sectors. The company trades on the Nasdaq under the ticker SSNC. Recently, it has been active in the capital markets, with multiple filings indicating a robust approach to financing.
What the Filing Says
The SEC filing states, "On November 6, 2026, SS&C Technologies Holdings, Inc. completed its previously announced upsized private offering of $1,200,000,000 aggregate principal amount of 2.75% Convertible Senior Notes due 2031." The notes will bear interest at a rate of 2.75% per year, payable semiannually.
Impact
This financial maneuver may significantly affect various stakeholders, including investors looking for convertible debt options and competitors in the prepackaged software sector. As SS&C strengthens its financial position, other companies may feel pressured to pursue similar financing strategies to remain competitive.
What's Next
The filing does not specify what happens next, but the successful completion of this offering positions SS&C for potential future growth initiatives and investments.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










